NVVRQ

TMTP1 is a five-amino acid (NVVRQ) tumor-homing peptide. TMTP1 slows the growth of tumor cells. TMTP1 serves as a diagnostic marker for hematological malignancies and acts as an anticancer drug carrier to enhance the cellular uptake rate of nanocarriers in tumor tissues. TMTP1 is applicable to research related to hematological malignancies, lymphoma, chronic myeloid leukemia, cervical cancer, and ovarian cancer.


Cat. No.: EX-A13961	Purity: >98%

	Chemical structure of NVVRQ

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
10mg	get quote	Inquire
100mg	get quote	Inquire
100mg	get quote	Inquire
1g	get quote	Inquire

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	1227627-77-1
Purity	>98%
Formula	C25H46N10O8
Mol Weight	614.6949
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Xiao M, et al.. TMTP1, a novel tumor-homing peptide, specifically targets hematological malignancies and their metastases. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban. 2011 Oct;31(5):608. [2]. Xu H, et al.. TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis. Theranostics. 2025;15(11):5420-5439. [3]. Zhou Y, et al.. Tumor targeting peptide TMTP1 modified Antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer. Journal of nanobiotechnology. 2024 Aug 13;22(1):483.
CoA	CoA of NVVRQ

Smiles:	[C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC(N)=O)N)=O)C(C)C)=O)[C@@H](C)C)=O)(C(N[C@@H](CCC(N)=O)C(O)=O)=O)CCCNC(=N)N


		Search